Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesions
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
PURPOSE: To identify qualitative MRI features of non-(contrast)-enhancing tumor (nCET) in glioblastoma's T2-FLAIR hyperintense lesion.
METHODS: Thirty-three histologically confirmed glioblastoma patients whose T1-, T2- and contrast-enhanced T1-weighted MRI and 11C-methionine positron emission tomography (Met-PET) were available were included in this study. Met-PET was utilized as a surrogate for tumor burden. Imaging features for identifying nCET were searched by qualitative examination of 156 targets. A new scoring system to identify nCET was established and validated by two independent observers.
RESULTS: Three imaging features were found helpful for identifying nCET; "Bulky gray matter involvement", "Around the rim of contrast-enhancement (Around-rim)," and "High-intensity on T1WI and low-intensity on T2WI (HighT1LowT2)" resulting in an nCET score = 2 × Bulky gray matter involvement - 2 × Around-rim + HighT1LowT2 + 2. The nCET score's classification performances of two independent observers measured by AUC were 0.78 and 0.80, with sensitivities and specificities using a threshold of four being 0.443 and 0.771, and 0.916 and 0.768, respectively. The weighted kappa coefficient for the nCET score was 0.946.
CONCLUSION: The current investigation demonstrated that qualitative assessments of glioblastoma's MRI might help identify nCET in T2/FLAIR high-intensity lesions. The novel nCET score is expected to aid in expanding treatment targets within the T2/FLAIR high-intensity lesions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
---|---|
Enthalten in: |
Journal of neuro-oncology - 165(2023), 2 vom: 02. Nov., Seite 251-259 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yamamoto, Shota [VerfasserIn] |
---|
Links: |
---|
Themen: |
AE28F7PNPL |
---|
Anmerkungen: |
Date Completed 01.12.2023 Date Revised 01.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11060-023-04454-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364091622 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM364091622 | ||
003 | DE-627 | ||
005 | 20231226094721.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11060-023-04454-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1213.xml |
035 | |a (DE-627)NLM364091622 | ||
035 | |a (NLM)37917281 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yamamoto, Shota |e verfasserin |4 aut | |
245 | 1 | 0 | |a Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesions |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.12.2023 | ||
500 | |a Date Revised 01.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a PURPOSE: To identify qualitative MRI features of non-(contrast)-enhancing tumor (nCET) in glioblastoma's T2-FLAIR hyperintense lesion | ||
520 | |a METHODS: Thirty-three histologically confirmed glioblastoma patients whose T1-, T2- and contrast-enhanced T1-weighted MRI and 11C-methionine positron emission tomography (Met-PET) were available were included in this study. Met-PET was utilized as a surrogate for tumor burden. Imaging features for identifying nCET were searched by qualitative examination of 156 targets. A new scoring system to identify nCET was established and validated by two independent observers | ||
520 | |a RESULTS: Three imaging features were found helpful for identifying nCET; "Bulky gray matter involvement", "Around the rim of contrast-enhancement (Around-rim)," and "High-intensity on T1WI and low-intensity on T2WI (HighT1LowT2)" resulting in an nCET score = 2 × Bulky gray matter involvement - 2 × Around-rim + HighT1LowT2 + 2. The nCET score's classification performances of two independent observers measured by AUC were 0.78 and 0.80, with sensitivities and specificities using a threshold of four being 0.443 and 0.771, and 0.916 and 0.768, respectively. The weighted kappa coefficient for the nCET score was 0.946 | ||
520 | |a CONCLUSION: The current investigation demonstrated that qualitative assessments of glioblastoma's MRI might help identify nCET in T2/FLAIR high-intensity lesions. The novel nCET score is expected to aid in expanding treatment targets within the T2/FLAIR high-intensity lesions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Glioblastoma | |
650 | 4 | |a MRI | |
650 | 4 | |a Non-contrast-enhancing tumor | |
650 | 4 | |a Qualitative feature | |
650 | 7 | |a Methionine |2 NLM | |
650 | 7 | |a AE28F7PNPL |2 NLM | |
700 | 1 | |a Okita, Yoshiko |e verfasserin |4 aut | |
700 | 1 | |a Arita, Hideyuki |e verfasserin |4 aut | |
700 | 1 | |a Sanada, Takahiro |e verfasserin |4 aut | |
700 | 1 | |a Sakai, Mio |e verfasserin |4 aut | |
700 | 1 | |a Arisawa, Atsuko |e verfasserin |4 aut | |
700 | 1 | |a Kagawa, Naoki |e verfasserin |4 aut | |
700 | 1 | |a Shimosegawa, Eku |e verfasserin |4 aut | |
700 | 1 | |a Nakanishi, Katsuyuki |e verfasserin |4 aut | |
700 | 1 | |a Kinoshita, Manabu |e verfasserin |4 aut | |
700 | 1 | |a Kishima, Haruhiko |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neuro-oncology |d 1993 |g 165(2023), 2 vom: 02. Nov., Seite 251-259 |w (DE-627)NLM012591793 |x 1573-7373 |7 nnns |
773 | 1 | 8 | |g volume:165 |g year:2023 |g number:2 |g day:02 |g month:11 |g pages:251-259 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11060-023-04454-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 165 |j 2023 |e 2 |b 02 |c 11 |h 251-259 |